|
Device | VENTANA PD-L1 (SP263) Assay |
Generic Name | Immunohistochemistry assay, antibody, programmed death-ligand 1 |
Applicant | Ventana Medical Systems, Inc. 1910 E. Innovation Park Dr. Tucson, AZ 85755 |
PMA Number | P160046 |
Supplement Number | S011 |
Date Received | 01/28/2022 |
Decision Date | 06/10/2022 |
Product Code |
PLS |
Advisory Committee |
Pathology |
Supplement Type | 135 Review Track For 30-Day Notice |
Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval for the addition of two new contract manufacturers as approved suppliers for component parts. |